Health and Human Services Department
HHS proposes to amend its Confidentiality of Substance Use Disorder Patient Records regulation, to clarify one of the conditions under which a court may authorize disclosure of confidential communications made by a patient to a part 2 program as defined in this regulation. This change will clarify that a court may authorize disclosure of confidential communications when the disclosure is necessary in connection with investigation or prosecution of an extremely serious crime, even if the extremely serious crime was not allegedly committed by the patient.
Document Headings Document headings vary by document type but may contain the following: the agency or agencies that issued and signed a document the number of the CFR title and the number of each part the document amends, proposes to amend, or is directly related to the agency docket number / agency internal file number the RIN which identifies each regulatory action listed in the Unified Agenda of Federal Regulatory and Deregulatory Actions See the Document Drafting Handbook for more details. Department of Health and Human Services 42 CFR Part 2 [SAMHSA-4162-20] RIN 0930-AA30 AGENCY: Substance Abuse and Mental Health Services Administration (SAMHSA), U.S. Department of Health and Human Services (HHS). ACTION: Notice of proposed rulemaking (NPRM). SUMMARY: HHS proposes to amend its Confidentiality of Substance Use Disorder Patient Records regulation, to clarify one of the conditions under which a court may authorize disclosure of confidential communications made by a patient to a part 2 program as defined in this regulation. This change will clarify that a court may authorize disclosure of confidential communications when the disclosure is necessary in connection with investigation or prosecution of an extremely serious crime, even if the extremely serious crime was not allegedly committed by the patient. DATES: To be assured consideration, comments must be received at one of the addresses provided below no later than 5 p.m. on September 25, 2019. ADDRESSES: You may submit comments, identified by Regulatory Information Number (RIN) 0930-AA30, by any of the following methods. Please submit your comments in only one of these ways to minimize the receipt of duplicate submissions. 1. Federal eRulemaking Portal: You may submit comments electronically at http://www.regulations.gov . Follow the instructions for submitting comments. This is the preferred method for the submission of comments. 2. Mail: Written comments must be sent to the following address: Attn: Mitchell B…
Other Federal Register documents from the same docket.
Confidentiality of Substance Use Disorder Patient Records
Confidentiality of Substance Use Disorder Patient Records
Mandatory Guidelines for Federal Workplace Drug Testing Programs-Oral/Fluid
Confidentiality of Substance Use Disorder Patient Records
Confidentiality of Substance Use Disorder Patient Records
Citation: 84 FR 44566
